Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
about
Warfarin initiation nomograms for venous thromboembolismDuration of treatment with vitamin K antagonists in symptomatic venous thromboembolismWarfarin initiation nomograms for venous thromboembolismWarfarin initiation nomograms for venous thromboembolismAssessing bleeding risk in patients taking anticoagulantsAntithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesWarfarin: almost 60 years old and still causing problemsClinically important deep vein thrombosis in the intensive care unit: a survey of intensivistsComparative risk impact of edoxaban in the management of stroke and venous thromboembolismRecurrent venous thromboembolism: what is the risk and how to prevent itMajor bleeding during secondary prevention of venous thromboembolism in patients who have completed anticoagulation: a systematic review and meta-analysisAtrial fibrillation: a review of recent studies with a focus on those from the duke clinical research instituteCare transitions in anticoagulation management for patients with atrial fibrillation: an emphasis on safetyWarfarin pharmacogenetics: does more accurate dosing benefit patients?Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysisStatins, inflammation and deep vein thrombosis: a systematic reviewRe-initiation of dabigatran and direct factor Xa antagonists after a major bleedDental extraction in patients on warfarin treatmentPulmonary embolism in hospital practice.Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.Latest medical treatment strategies for venous thromboembolism.[Treatment of venous thromboembolism].Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) studyCost-effectiveness of additional catheter-directed thrombolysis for deep vein thrombosis.Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testingDetermination of free and total warfarin concentrations in plasma using UPLC MS/MS and its application to a patient samples.Thromboembolism.Serious bleeding events due to warfarin and antibiotic co-prescription in a cohort of veterans.Implementing genotype-guided antithrombotic therapy.Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics.Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registryImpact of age, CYP2C9 genotype and concomitant medication on the rate of rise for prothrombin time during the first 30 days of warfarin therapy.Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH.Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.Duration of anticoagulant therapy for venous thromboembolism: balancing benefits and harms on the long term.Dual processing model of medical decision-making.Negative D-dimer result to exclude recurrent deep venous thrombosis: a management trial.Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry.
P2860
Q24186324-646E80EE-7E26-422C-BF29-3C10A421C292Q24194466-20881BDD-BB54-4824-B79C-A57CA7EE3BA3Q24201274-3F320F81-085B-41CC-ABB9-6659FEE811B5Q24240381-0510A9F5-1354-4DDD-8D22-D2856B9B1017Q24619070-917999B3-6D82-46D5-BCD0-F059DE1AD1A1Q24633053-A4C29113-8C06-4F28-8453-676E3EC6D007Q24678632-45409220-F5B4-4F4D-A3C4-2C1043A5624EQ24791367-3ACCF58D-FDE2-4EA1-9BBB-350A1D9EBE11Q26746233-133588C9-6955-4FC8-85D7-DDB3C654A394Q26826847-8542D075-90FE-4839-AB03-63BE0A7113D1Q26828750-64FEA34A-99AA-4488-8D68-2EB2199075DEQ26851235-7FF9C658-BAF2-4607-B1C6-BFB81A4D9E03Q27025527-E8A9ABD9-BB2D-4361-9EDF-3D77459C3F05Q27027304-67551CAD-039C-45E7-89B4-55D373ADBA2CQ27027477-4A3BD3ED-CA9E-4708-9765-F70B7460336DQ27027545-2BDF2B80-F5A0-4103-B32F-15E608B631CBQ28067358-430C6D0C-E5A0-4113-A60F-AE09E000231DQ28246951-7354208D-DCC3-4A34-8DFE-B5CC624D362BQ30476617-BB371578-B404-44B0-B6C1-F1EB2EA9E301Q33311569-83180EE1-99C1-45CC-B99B-486AF0FA65A3Q33375535-EA6325DC-9E62-4AA4-BE59-DA4D0DD899FEQ33387992-83E7C561-5DFF-4721-B0C1-233DE4E08B3FQ33396864-2B5CA29F-53A9-4AA3-AEEE-1FF9C4F23E50Q33517162-3ED0EDFA-ABE6-4070-B3B8-0AFB46B64D92Q33590496-1FA2EF62-86C3-4D43-B870-8C2F21823946Q33637113-5EBE5DE2-66F7-4115-B90B-AB053139249AQ33813830-590BBE9B-E818-4121-B29C-40844AC4A499Q33837117-B7D2DFBF-150E-40FE-8EA5-FB77EE7B48E9Q33840400-318BD9B6-C9F6-461E-88A4-35AC40E72653Q33978811-52F8A086-99D1-446F-BD58-575436B5A64EQ33990428-F129E1BE-42AD-4671-9AD0-5EFBBBC69967Q33990441-CC75A57E-6FCC-478E-B9D7-D71958421463Q34019616-ACEC2E33-96F3-43D3-9BCF-FD9E0667FFAAQ34146486-3AE15F8F-B643-4BB2-A087-1FD7CDA98504Q34254243-72268E3E-788D-4B5A-A6D1-7EB69E7ACE86Q34262668-D8B7C471-5809-4471-829C-CFC2A112769BQ34284224-A8597F3D-8B5E-4B2A-8062-01D6990673CBQ34401953-34B4EE52-D456-4A84-8963-F5A54AE6EBF7Q34407160-755DB534-AC08-4030-BD8B-FDDD542B5F5EQ34554492-893F531B-EEEC-4FA9-88E9-345BD3C1BD0F
P2860
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@en
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@nl
type
label
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@en
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@nl
prefLabel
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@en
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@nl
P2093
P1476
Clinical impact of bleeding in ...... omboembolism: a meta-analysis.
@en
P2093
James D Douketis
Lori-Ann Linkins
Peter T Choi
P304
P356
10.7326/0003-4819-139-11-200312020-00007
P407
P577
2003-12-01T00:00:00Z